SCHEMBL29567018

SCHEMBL29567018

CN1CCN(c2cccc(Oc3nc(NS(=O)(=O)c4cnn(C)c4)nc(Cl)c3C(F)(F)F)c2Cl)CC1

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HTR6 P50406 7/20 0.35
▸ HTR1A P08908 6/20 0.35
▸ DRD2 P14416 4/20 0.35
▸ DRD3 P35462 3/20 0.35
▸ DRD4 P21917 2/20 0.35
▸ HTR2A P28223 1/20 0.35
▸ HTR2C P28335 1/20 0.35
▸ TIPARP Q7Z3E1 1/20 0.35
▸ CTSC P53634 2/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ HTR7 P34969 4/20 0.34
▸ SCN9A Q15858 1/20 0.33
▸ BRD4 O60885 1/20 0.33
▸ ADRA1D P25100 1/20 0.33
▸ ADRA1A P35348 1/20 0.33
▸ ADRA1B P35368 1/20 0.33
▸ MET P08581 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26808480 1.00 HTR6 (0.35) HTR6HTR1ADRD2DRD3DRD4
SCHEMBL24309538 0.94 HTR6 (0.34) HTR6HTR1ADRD2DRD3DRD4
SCHEMBL29566783 0.94 HTR6 (0.34) HTR6HTR1ADRD2DRD3DRD4
SCHEMBL26808486 0.88 HTR1A (0.34) HTR6HTR1ADRD2DRD3DRD4
SCHEMBL29566556 0.87 HTR1A (0.41) HTR6HTR1ADRD2DRD3DRD4
SCHEMBL24309483 0.87 HTR1A (0.41) HTR6HTR1ADRD2DRD3DRD4
SCHEMBL29566696 0.85 CTSC (0.46) HTR6HTR1ADRD3HTR2AHTR2C
SCHEMBL24309808 0.85 CTSC (0.46) HTR6HTR1ADRD3HTR2AHTR2C
SCHEMBL26811965 0.85 HTR6 (0.33) HTR6HTR1ADRD2DRD3DRD4
SCHEMBL24309367 0.84 CTSC (0.42) CTSCHTR7BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback